Dr. Srihari’s clinical and research interests are focused on the evaluation and treatment of individuals with psychotic disorders. After completing psychiatry residency training and a fellowship in schizophrenia at Yale, he joined the staff at the Connecticut Mental Health Center and the faculty at Yale in 2005. In 2006, he founded the Program for Specialized Treatment Early in Psychosis (STEP), which subsequently completed the first U.S. randomized controlled trial to test the effectiveness of a comprehensive model of early intervention.
With the benefit of support from the Connecticut Department of Mental Health and Addictions (DMHAS), STEP was able to hire dedicated staff in 2013. In 2014, the Program initiated a population health approach to transform pathways into care for young individuals in southern Connecticut confronting the new onset of a psychotic illness. In 2015, STEP launched MindMap, an educational campaign funded by the National Institute of Mental Health (NIMH) in efforts to reduce the duration of untreated psychosis (DUP) in 10 surrounding towns.
Dr. Srihari continues to direct the STEP Program, which now includes an established clinical service, education for students and area providers, and a broad range of research to advance treatments for psychotic illnesses.
“Treatment works: the earlier, the better.”